Key result
Nortriptyline and phenelzine cause greater orthostatic falls in systolic pressure versus placebo.
Why the study?
Does nortriptyline or phenelzine increase orthostatic fall in systolic pressure compared to placebo in elderly patients with major depression?
RCT (n=75)
Does nortriptyline or phenelzine increase orthostatic fall in systolic pressure compared to placebo in elderly patients with major depression?
In elderly depressed patients, both nortriptyline and phenelzine cause a significant orthostatic fall in systolic blood pressure compared to placebo.
Answers are grounded in this paper and cite their sources.
Warrants orthostatic BP monitoring in elderly patients on nortriptyline or phenelzine; confirms comparable risk with both agents.
Seventy-five patients, 55 years or older, were treated for major depression with either nortriptyline, phenelzine, or placebo during a 7-week period. There was a significantly greater mean orthostatic fall in systolic pressure in patients treated with nortriptyline and phenelzine as compared to the placebo group, but no significant difference was evident between the nortriptyline and phenelzine groups. The orthostatic changes appeared during the first week of treatment and were not correlated with plasma level of nortriptyline, percent platelet monoamine oxidase inhibition, or pretreatment orthostatic changes.
No takes yet. Share an insight, caveat, or question.
Georgotas et al. (1987) conducted an RCT in major depression (n=75). Nortriptyline and phenelzine vs. Placebo was evaluated on mean orthostatic fall in systolic pressure. Nortriptyline and phenelzine caused a significantly greater mean orthostatic fall in systolic pressure compared to placebo, with no significant difference between the active drugs.
Synapse has enriched 10 related papers. Consider them for comparative context: